24 results
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
4 Jun 24
Additional proxy soliciting materials
5:25pm
trust him. Given Mr. Selce's lack of transparency (discussed further below), combined with charges of unethical and illegal conduct, the Company has
PX14A6G
MKT Capital Ltd.
26 Apr 23
Letter to shareholders
10:20am
reduces pay transparency for Aurinia shareholders. The majority of the equity awards did not include performance conditions and the performance shares were
DEF 14A
i86y ltu3l
10 May 21
Definitive proxy
4:06pm
PRE 14A
k26zi5y4
27 Apr 21
Preliminary proxy
4:32pm
10-K
poirf15 tkmj
24 Feb 21
Annual report
4:09pm
SUPPL
1h8qme
23 Jul 20
Supplemental materials (foreign)
4:06pm
SUPPL
n3vevbx45
26 Jun 20
Supplemental materials (foreign)
4:08pm
F-10/A
kv5tky4tgcwm5fd
17 Jun 20
Registration of securities (Canada) (amended)
4:35pm
F-10
zo8vfogcebuhj
29 May 20
Registration of securities (Canada)
4:07pm
SUPPL
t7xu5y
10 Dec 19
Supplemental materials (foreign)
4:31pm
SUPPL
tia9buce ghg563ej
9 Dec 19
Supplemental materials (foreign)
6:35am
SUPPL
6qkg cblanfku
13 Sep 19
Supplemental materials (foreign)
5:05pm
SUPPL
xolai76hk
30 Nov 18
Supplemental materials (foreign)
5:23pm
F-10/A
eei7j2trqp1jr
16 Oct 15
Registration of securities (Canada) (amended)
12:00am
6-K
EX-99.5
965xulvy vo6a8v
15 Aug 14
Aurinia Reports Second Quarter 2014 Financial Results
12:00am
6-K
EX-99.4
06dxxgvc 9211m2
15 Aug 14
Aurinia Reports Second Quarter 2014 Financial Results
12:00am